{"id":"https://openalex.org/W1995525871","doi":"https://doi.org/10.1097/00006231-199801000-00009","title":"In vitro effect of contrast agents during immunoradiometric assay for tumour-associated antigens","display_name":"In vitro effect of contrast agents during immunoradiometric assay for tumour-associated antigens","publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W1995525871","doi":"https://doi.org/10.1097/00006231-199801000-00009","mag":"1995525871","pmid":"https://pubmed.ncbi.nlm.nih.gov/9515548"},"language":"en","primary_location":{"id":"doi:10.1097/00006231-199801000-00009","doi":"https://doi.org/10.1097/00006231-199801000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00006231-199801000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S108023290","display_name":"Nuclear Medicine Communications","issn_l":"0143-3636","issn":["0143-3636","1473-5628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nuclear Medicine Communications","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://repo.qst.go.jp/records/44064","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101744329","display_name":"Norihiro Watanabe","orcid":"https://orcid.org/0009-0006-7851-0598","observed_orcids":["https://orcid.org/0009-0006-7851-0598"]},"institutions":[{"id":"https://openalex.org/I165735259","display_name":"Gunma University","ror":"https://ror.org/046fm7598","country_code":"JP","type":"education","lineage":["https://openalex.org/I165735259"]},{"id":"https://openalex.org/I4210164827","display_name":"Gunma University Hospital","ror":"https://ror.org/05kq1z994","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210164827"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"N. WATANABE","raw_affiliation_strings":["Department of Nuclear Medicine, Gunma University School of Medicine, Japan","Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Gunma University School of Medicine, Japan","institution_ids":["https://openalex.org/I165735259","https://openalex.org/I4210164827"]},{"raw_affiliation_string":"Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan","institution_ids":["https://openalex.org/I165735259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034452868","display_name":"Noboru Oriuchi","orcid":"https://orcid.org/0000-0002-5557-0620","observed_orcids":["https://orcid.org/0000-0002-5557-0620"]},"institutions":[{"id":"https://openalex.org/I165735259","display_name":"Gunma University","ror":"https://ror.org/046fm7598","country_code":"JP","type":"education","lineage":["https://openalex.org/I165735259"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"N. ORIUCHI","raw_affiliation_strings":["Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan","institution_ids":["https://openalex.org/I165735259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045592295","display_name":"Takahiro Higuchi","orcid":"https://orcid.org/0000-0001-9711-7835","observed_orcids":["https://orcid.org/0000-0001-9711-7835","https://orcid.org/0000-0001-7887-8890"]},"institutions":[{"id":"https://openalex.org/I165735259","display_name":"Gunma University","ror":"https://ror.org/046fm7598","country_code":"JP","type":"education","lineage":["https://openalex.org/I165735259"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T. HIGUCHI","raw_affiliation_strings":["Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan","institution_ids":["https://openalex.org/I165735259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012921572","display_name":"Masashi Yukihiro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165735259","display_name":"Gunma University","ror":"https://ror.org/046fm7598","country_code":"JP","type":"education","lineage":["https://openalex.org/I165735259"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. YUKIHIRO","raw_affiliation_strings":["Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan","institution_ids":["https://openalex.org/I165735259"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Y. FUKUSHIMA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165735259","display_name":"Gunma University","ror":"https://ror.org/046fm7598","country_code":"JP","type":"education","lineage":["https://openalex.org/I165735259"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. FUKUSHIMA","raw_affiliation_strings":["Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan","institution_ids":["https://openalex.org/I165735259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010422674","display_name":"Katsumi Tomiyoshi","orcid":"https://orcid.org/0000-0002-1679-6483","observed_orcids":["https://orcid.org/0000-0002-1679-6483"]},"institutions":[{"id":"https://openalex.org/I165735259","display_name":"Gunma University","ror":"https://ror.org/046fm7598","country_code":"JP","type":"education","lineage":["https://openalex.org/I165735259"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K. TOMIYOSHI","raw_affiliation_strings":["Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan","institution_ids":["https://openalex.org/I165735259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016721695","display_name":"Tatsuya Hirano","orcid":"https://orcid.org/0000-0002-4219-6473","observed_orcids":["https://orcid.org/0000-0002-4219-6473"]},"institutions":[{"id":"https://openalex.org/I165735259","display_name":"Gunma University","ror":"https://ror.org/046fm7598","country_code":"JP","type":"education","lineage":["https://openalex.org/I165735259"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T. HIRANO","raw_affiliation_strings":["Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan","institution_ids":["https://openalex.org/I165735259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102815975","display_name":"Takaaki Inoue","orcid":"https://orcid.org/0000-0002-6050-5452","observed_orcids":["https://orcid.org/0000-0002-6050-5452"]},"institutions":[{"id":"https://openalex.org/I165735259","display_name":"Gunma University","ror":"https://ror.org/046fm7598","country_code":"JP","type":"education","lineage":["https://openalex.org/I165735259"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T. INOUE","raw_affiliation_strings":["Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan","institution_ids":["https://openalex.org/I165735259"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109321454","display_name":"K Endo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165735259","display_name":"Gunma University","ror":"https://ror.org/046fm7598","country_code":"JP","type":"education","lineage":["https://openalex.org/I165735259"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K. ENDO","raw_affiliation_strings":["Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Gunma University School of Medicine, 3\u201339-22 Showa-machi, Maebashi-shi, Gunma 371, Japan","institution_ids":["https://openalex.org/I165735259"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7832,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.82974743,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"19","issue":"1","first_page":"63","last_page":"70"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/3607","display_name":"Medical Laboratory Technology"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/3607","display_name":"Medical Laboratory Technology"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12867","display_name":"Advanced Biosensing Techniques and Applications","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/contrast-media","display_name":"contrast media","score":0.9309999942779541},{"id":"https://openalex.org/keywords/immunoradiometric-assay","display_name":"immunoradiometric assay","score":0.8809999823570251},{"id":"https://openalex.org/keywords/assay-interference","display_name":"assay interference","score":0.8939999938011169},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.9269999861717224},{"id":"https://openalex.org/keywords/carcinoembryonic-antigen","display_name":"carcinoembryonic antigen","score":1.0},{"id":"https://openalex.org/keywords/tissue-polypeptide-antigen","display_name":"tissue polypeptide antigen","score":0.9990000128746033},{"id":"https://openalex.org/keywords/iomeprol","display_name":"iomeprol","score":0.8420000076293945},{"id":"https://openalex.org/keywords/ioversol","display_name":"ioversol","score":0.7940000295639038},{"id":"https://openalex.org/keywords/iopamidol","display_name":"iopamidol","score":0.9660000205039978},{"id":"https://openalex.org/keywords/iohexol","display_name":"iohexol","score":0.9629999995231628},{"id":"https://openalex.org/keywords/gd-dtpa","display_name":"Gd-DTPA","score":0.871999979019165},{"id":"https://openalex.org/keywords/serum-tumor-markers","display_name":"serum tumor markers","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C2778758028","wikidata":"https://www.wikidata.org/wiki/Q19597582","display_name":"Immunoradiometric assay","level":3,"score":0.8634724617004395},{"id":"https://openalex.org/C2776982972","wikidata":"https://www.wikidata.org/wiki/Q424788","display_name":"Iopamidol","level":3,"score":0.7754859924316406},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6903067231178284},{"id":"https://openalex.org/C2779093167","wikidata":"https://www.wikidata.org/wiki/Q410683","display_name":"Iohexol","level":3,"score":0.6730273365974426},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6242727041244507},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6010720729827881},{"id":"https://openalex.org/C176685330","wikidata":"https://www.wikidata.org/wiki/Q857638","display_name":"Radioimmunoassay","level":2,"score":0.5907593965530396},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.46151208877563477},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34102657437324524},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28131037950515747},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26835644245147705},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15907257795333862},{"id":"https://openalex.org/C2779786684","wikidata":"https://www.wikidata.org/wiki/Q906156","display_name":"Contrast medium","level":2,"score":0.14646270871162415},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.0},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D002272","descriptor_name":"Carcinoembryonic Antigen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003287","descriptor_name":"Contrast Media","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007472","descriptor_name":"Iohexol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007479","descriptor_name":"Iopamidol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D014283","descriptor_name":"Triiodobenzoic Acids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015295","descriptor_name":"Antigens, Tumor-Associated, Carbohydrate","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015592","descriptor_name":"Immunoradiometric Assay","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019396","descriptor_name":"Tissue Polypeptide Antigen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019786","descriptor_name":"Gadolinium DTPA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/00006231-199801000-00009","doi":"https://doi.org/10.1097/00006231-199801000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00006231-199801000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S108023290","display_name":"Nuclear Medicine Communications","issn_l":"0143-3636","issn":["0143-3636","1473-5628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nuclear Medicine Communications","raw_type":"journal-article"},{"id":"pmid:9515548","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9515548","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nuclear medicine communications","raw_type":"Comparative Study"},{"id":"pmh:oai:irdb.nii.ac.jp:01116:0003807667","doi":null,"is_oa":true,"landing_page_url":"https://repo.qst.go.jp/records/44064","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nuclear Medicine Communications","raw_type":"journal article"},{"id":"pmh:oai:repo.qst.go.jp:00010059","doi":null,"is_oa":false,"landing_page_url":"http://repo.nirs.go.jp/?action=repository_uri&amp;item_id=10059","pdf_url":null,"source":{"id":"https://openalex.org/S4377196694","display_name":"QST-Repository (National Institutes for Quantum and Radiological Science and Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210114217","host_organization_name":"National Institutes for Quantum Science and Technology","host_organization_lineage":["https://openalex.org/I4210114217"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:01116:0003807667","doi":null,"is_oa":true,"landing_page_url":"https://repo.qst.go.jp/records/44064","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nuclear Medicine Communications","raw_type":"journal article"},"sustainable_development_goals":[{"score":0.9074000120162964,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3000674140","https://openalex.org/W2378539545","https://openalex.org/W2164811182","https://openalex.org/W2032587803","https://openalex.org/W2034237088","https://openalex.org/W2810514304","https://openalex.org/W1964754123","https://openalex.org/W2155498858","https://openalex.org/W1936643030","https://openalex.org/W1917079187"],"abstract_inverted_index":{"The":[0,124],"aim":[1],"of":[2,15,27,74,86,121,126,129,145,160,166,184,201,229,232],"this":[3],"study":[4],"was":[5,41,80,134,156,171],"to":[6,104,118,207,217],"investigate":[7],"if":[8],"contrast":[9,45,99,122,146,167,186,195,233],"agents":[10,100,187,196],"interfere":[11],"with":[12,43,95,109,140],"the":[13,72,83,96,106,112,119,138,163,172,178,185,199,230,236],"performance":[14],"an":[16],"immunoradiometric":[17],"assay":[18],"(IRMA)":[19],"in":[20,60,77,116,137,148,208],"vitro":[21,209],"for":[22,181],"serum":[23,84,127],"tumour-associated":[24],"antigen.":[25],"Each":[26],"five":[28],"carcinoembryonic":[29],"antigen":[30,38,204],"(CEA)-positive":[31],"sera,":[32],"CA-130-positive":[33],"sera":[34,40],"and":[35,57,66,82,89,93,111,132,175,203,205],"tissue":[36],"polypeptide":[37],"(TPA)-positive":[39],"mixed":[42],"six":[44],"agents:":[46],"Ioversol":[47],"350,":[48],"Iopamidol":[49],"370,":[50],"Iomeprol":[51,53,153,169],"300,":[52],"400,":[54,154],"Iohexol":[55],"300":[56],"Gadopenteic":[58,176],"acid":[59,177],"50:50,":[61],"50:20,":[62],"50:5.0,":[63],"50:1.0,":[64],"50:0.5":[65],"50:0.1":[67],"microl":[68,144],"proportions.":[69],"Following":[70],"IRMA,":[71],"interference":[73],"binding":[75,107],"rates":[76,114],"each":[78,182],"mixture":[79],"calculated,":[81],"concentrations":[85,128,165],"CEA,":[87,130],"CA-130":[88,131],"TPA":[90,133],"were":[91,102,115],"estimated":[92],"compared":[94],"originals.":[97],"All":[98],"used":[101],"able":[103],"inhibit":[105],"rate":[108],"IRMA":[110,183],"inhibition":[113,159,210],"proportion":[117],"amount":[120],"agent.":[123],"detection":[125,161],"significantly":[135],"inhibited":[136],"mixtures":[139],"more":[141],"than":[142],"5.0":[143],"agent":[147,234],"all":[149],"cases.":[150],"Apart":[151],"from":[152],"there":[155],"no":[157],"significant":[158],"at":[162],"lowest":[164],"agents.":[168],"400":[170],"strongest":[173],"inhibitor":[174,180],"weakest":[179],"employed.":[188],"In":[189],"conclusion,":[190],"our":[191],"results":[192],"demonstrate":[193],"that":[194],"may":[197],"reduce":[198],"immunoreaction":[200],"antibody":[202],"lead":[206],"during":[211],"immunoassays.":[212],"It":[213],"would":[214],"be":[215],"unwise":[216],"perform":[218],"any":[219],"plasma/serum":[220],"immunoassay":[221],"on":[222],"a":[223],"sample":[224],"collected":[225],"within":[226],"24":[227],"h":[228],"administration":[231],"considering":[235],"pharmacokinetics.":[237]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
